US Edition
How cannabis reform in the U.S. could impact international markets
Summary by GreenState
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
How cannabis reform in the U.S. could impact international markets
In October 2022, President Joe Biden directed the US Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) to review cannabis’s scheduling under the Controlled Substances Act. Currently, cannabis is a Schedule I narcotic in the US, which is defined as “drugs, chemicals or substances with no currently accepted medical use and a high potential for abuse.” Cannabis currently holds the same standing as heroin, l…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
